SIM
SAGE

Strategic Investment Management’s Sage Therapeutics SAGE Stock Holding History

Strategic Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,013
Closed -$230K – 140
2016
Q3 		$230K Buy
+5,013
New +$204K 0.16% 58

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Strategic Investment Management's SAGE Position: Q4 2016 in Review

Strategic Investment Management sold out of Sage Therapeutics (SAGE) in Q4 2016, closing a stake of 5,013 shares — an estimated $230K sold.

Strategic Investment Management first reported a position in SAGE in Q3 2016 and held it in 1 quarter. The position peaked at $230K in Q3 2016. 166 funds tracked by Wall St. Rank hold SAGE as of Q4 2016.

  • Strategic Investment Management reported no remaining Sage Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Strategic Investment Management sold 5,013 Sage Therapeutics shares in Q4 2016, an estimated $230K.
  • Strategic Investment Management first reported a position in Sage Therapeutics in Q3 2016 and held it in 1 quarter.
  • Strategic Investment Management's Sage Therapeutics position peaked at $230K in Q3 2016.
  • 166 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2016.

Based on Strategic Investment Management's 13F filing for Q4 2016, filed 15 Feb 2017.